02 Oct2015

BI’s type 2 diabetes drug can lower cardio risks too: Study

Posted in News, World

Jardiance, a diabetes drug by Boehringer Ingelheim and Eli Lilly, has demonstrated positive result in reducing cardiovascular risk in patients with type 2 diabetes

Jardiance has demonstrated positive result in reducing cardiovascular risk in patients with type 2 diabetes

Singapore: Jardiance, a diabetes drug by Boehringer Ingelheim and Eli Lilly, has demonstrated positive result in reducing cardiovascular risk and cardiovascular death in patients with type 2 diabetes (T2D).

02 Oct2015

‘Gene therapy pipeline in oncology is rich but at early stage’

Posted in News, World

There are 266 pipeline gene therapies in active development for oncology, more than double that of central nervous system disorders, says GBI Research

Gene therapy pipeline in oncology gets strong

Singapore: Despite few products having so far reached the market and captured strong revenues, the gene therapy pipeline remains large, with 906 products in active development across all stages, highlights analysis firm GBI Research.

Live tweets

Twitter response: "Could not authenticate you."

Contact Us

Do you have any queries?

Quick Links

About | T&C | Organization | FAQ